Previous 10 | Next 10 |
MENLO PARK, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating the effects of the hormo...
JOHN HANCOCK TAX-ADVANTAGED DIVIDEND INCOME FUND PR Newswire NOTICE TO SHAREHOLDERS – SOURCES OF DISTRIBUTION UNDER SECTION 19(a) BOSTON , July 31, 2023 /PRNewswire/ - John Hancock Tax-Advantaged Dividend Income Fund (NYSE: HTD) (the "Fund"), ...
MENLO PARK, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on August 2, 2023. The company will also host a conference call that day at 5:00 p.m. Eastern Time ...
Phase 1b study demonstrates that miricorilant, a selective cortisol modulator, effectively reduces liver fat, improves liver health and key metabolic and lipid measures and is well-tolerated Corcept will initiate a Phase 2b study in the fourth quarter MENLO PARK, Calif., July 17...
2023-07-16 06:10:11 ET Summary In June, the broader indexes headed higher, with more participation outside of only the mega-cap growth names. As usual, I continue to put capital to work every month, but I've also been letting some cash accumulate, too, as the broader indexes conti...
2023-07-03 15:03:27 ET Summary The Beta coefficient measures the behavior of a security relative to the market: a Beta greater than one indicates the investment is more volatile than the market, and vice versa. Standard Deviation, on the other hand, measures the range of an invest...
2023-06-29 06:40:18 ET Summary The John Hancock Tax-Advantaged Dividend Income Fund primarily invests in dividend-paying equity securities. It has delivered modest long-term returns with higher than benchmark volatility, and its returns appear to be sufficient to fund its distribu...
2023-06-28 14:30:34 ET Summary Investors today are in desperate need of income as inflation has not been dropping nearly as fast as the headlines are leading us to believe. John Hancock Tax-Advantaged Dividend Income Fund invests primarily in utilities and other high-yielding comm...
Relacorilant plus nab-paclitaxel improved progression-free survival (PFS), duration of response (DoR) and overall survival (OS), without increasing side effects, compared to nab-paclitaxel monotherapy Confirmatory Phase 3 ROSELLA trial underway, with planned enrollment of 360 patients i...
2023-06-17 09:00:00 ET Summary Retirees, by the very definition of retirement, need to be financially independent. However, even for folks who are several years away from retirement, it can offer great benefits. We will go over our strategy as to how a diversified income and growt...
News, Short Squeeze, Breakout and More Instantly...
John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest Company Name:
HTD Stock Symbol:
NYSE Market:
2024-07-12 04:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 05:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Results from the CATALYST clinical trial were presented at the American Diabetes Association’s 84 th Scientific Sessions at a featured plenary session titled: “Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes” With 1,055 patients enro...